As the industry leader in providing solutions for RNA research and drug development success, Eclipsebio is dedicated to sponsoring events to that bring together world experts to share their latest discoveries while also supporting the career development of junior scientists.
Eclipsebio is proud to announce our sponsorship of the 2025 Gordon Research Conference on Decoding Microproteins Across Evolution and Disease in Barcelona. This conference will include discussions on the translation of small open reading frames (ORFs) and the role of micropeptides in disease and therapeutic development.
If you are interested in making your own discoveries with our comprehensive solutions for therapeutic development or academic research, contact our team of RNA experts today.
Latest news
2025 Data Catalyst Award Announcement
To support researchers as they generate RNA datasets, Eclipsebio is proud to announce the 2025 Data Catalyst Award. Winners of the award will obtain matching funds to cover the cost of generating their control datasets.
Decoding Microproteins Across Evolution and Disease
Eclipsebio is proud to announce their sponsorship of the 2025 Gordon Research Conference on Decoding Microproteins Across Evolution and Disease in Barcelona.
Eclipsebio Expands eMERGE™ Platform with eSENSE dsRNA™ for dsRNA Quantification and Localization
SAN DIEGO, September 3, 2024 — Eclipse Bioinnovations, Inc. (Eclipsebio), the leader in developing precision solutions for RNA-based and RNA-targeting therapeutics, today announced the launch of its eSENSE dsRNA™ assay. eSENSE dsRNA is a next-generation sequencing method for the robust quantification, localization, and optimization of double-stranded RNA (dsRNA) contaminants in RNA-based vaccines and therapeutics. “By […]
RNA and AI Symposium 2024
Eclipsebio is proud to announce their sponsorship of RNA and AI Symposium in San Diego. The one-day event will feature discussions on the intersection of AI and RNA drug development.